Trademark: 87315576
Word
GALXC
Status Date
Tuesday, August 18, 2020
Filing Date
Friday, January 27, 2017
Published for Opposition
Tuesday, December 19, 2017
5 Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; Oligonucleotide delivery agents for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
40 Custom manufacture of oligonucleotides for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders
42 Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections
Color is not claimed as a feature of the mark.
The mark consists of the term "GALXC" in stylized font with the letter "X" shown in an enlarged image.
Feb 25, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 25, 2021
Teas Change Of Correspondence Received
Feb 25, 2021
Teas Change Of Owner Address Received
Aug 19, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 18, 2020
Extension 5 Granted
Aug 12, 2020
Extension 5 Filed
Aug 18, 2020
Case Assigned To Intent To Use Paralegal
Aug 12, 2020
Teas Extension Received
Jun 4, 2020
Assigned To Examiner
Feb 15, 2020
Notice Of Approval Of Extension Request E-Mailed
Feb 13, 2020
Extension 4 Granted
Feb 13, 2020
Extension 4 Filed
Feb 13, 2020
Teas Extension Received
Aug 14, 2019
Notice Of Approval Of Extension Request E-Mailed
Aug 12, 2019
Extension 3 Granted
Aug 12, 2019
Extension 3 Filed
Aug 12, 2019
Teas Extension Received
Jun 10, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 10, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 12, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 10, 2019
Extension 2 Granted
Jan 10, 2019
Extension 2 Filed
Jan 10, 2019
Teas Extension Received
Aug 15, 2018
Notice Of Approval Of Extension Request E-Mailed
Aug 13, 2018
Extension 1 Granted
Aug 13, 2018
Extension 1 Filed
Aug 13, 2018
Teas Extension Received
Jul 23, 2018
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 13, 2018
Noa E-Mailed - Sou Required From Applicant
Dec 19, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 19, 2017
Published For Opposition
Nov 29, 2017
Notification Of Notice Of Publication E-Mailed
Nov 15, 2017
Approved For Pub - Principal Register
Nov 15, 2017
Teas/Email Correspondence Entered
Nov 15, 2017
Correspondence Received In Law Office
Nov 14, 2017
Assigned To Lie
Nov 2, 2017
Teas Request For Reconsideration Received
Aug 7, 2017
Notification Of Final Refusal Emailed
Aug 7, 2017
Final Refusal E-Mailed
Aug 7, 2017
Final Refusal Written
Jul 28, 2017
Teas/Email Correspondence Entered
Jul 27, 2017
Correspondence Received In Law Office
Jul 27, 2017
Teas Response To Office Action Received
Apr 25, 2017
Notification Of Non-Final Action E-Mailed
Apr 25, 2017
Non-Final Action E-Mailed
Apr 25, 2017
Non-Final Action Written
Apr 24, 2017
Assigned To Examiner
Jan 31, 2017
New Application Office Supplied Data Entered In Tram
Jan 31, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
